Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Adacel Polio |
| Active Ingredients: | Diphtheria toxoid, adsorbed 2IU Pertactin 3mcg Pertussis filamentous haemagglutinin 5mcg Pertussis fimbriae 2+3 5mcg Pertussis toxoid, adsorbed 2.5mcg Polio virus type 1 40DAgU Polio virus type 2 8DAgU Polio virus type 3 32DAgU Tetanus toxoid 20IU |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturer: | Sanofi Pasteur Limited, Toronto, Canada |
| Product: | Bepanthen tattoo |
| Active Ingredient: | Dexpanthenol 50mg/g |
| Dosage Form: | Topical ointment |
| New Zealand Sponsor: | Bayer New Zealand Limited |
| Manufacturer: | GP Grenzach Produktions GmbH, Grenzach-Wyhlen, Germany |
| Product: | Trazimera |
| Active Ingredient: | Trastuzumab 150mg |
| Dosage Form: | Powder for infusion concentrate |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Belgium NV, Puurs, Belgium |
| Product: | Trazimera |
| Active Ingredient: | Trastuzumab 440mg |
| Dosage Form: | Powder for infusion concentrate with diluent |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer Manufacturing Belgium NV, Puurs, Belgium |
Dated this 5th day of September 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).